Publicacións (10) Publicacións de Jesús García. Gómez

filter_list Cancer Research

2023

  1. The Frequency of Specific KRAS Mutations, and Their Impact on Treatment Choice and Survival, in Patients With Metastatic Colorectal Cancer

    Oncologist, Vol. 28, Núm. 10, pp. E902-E909

2021

  1. Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer

    Clinical and Translational Oncology, Vol. 23, Núm. 7, pp. 1272-1280

  2. PD-L1 expression and immune cells in anaplastic carcinoma and poorly differentiated carcinoma of the human thyroid gland: A retrospective study

    Oncology Letters, Vol. 22, Núm. 1

2020

  1. Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram

    Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 351-359

2019

  1. Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers

    Cancer Medicine, Vol. 8, Núm. 3, pp. 882-889

2016

  1. Ki-67 is a prognostic marker for hormone receptor positive tumors

    Clinical and Translational Oncology, Vol. 18, Núm. 10, pp. 996-1002

2014

  1. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

    Cancer, Vol. 120, Núm. 10, pp. 1453-1461

2013

  1. SEOM guide to antiemetic prophylaxis in cancer patients treated with chemotherapy 2013

    Clinical and Translational Oncology, Vol. 15, Núm. 12, pp. 1030-1036

  2. Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients

    Supportive Care in Cancer, Vol. 21, Núm. 1, pp. 343-355

2010

  1. SEOM clinical guidelines for the treatment of antiemetic prophylaxis in cancer patients receiving chemotherapy

    Clinical and Translational Oncology, Vol. 12, Núm. 11, pp. 770-774